Overview

Switch to DOVATO in Patients Suppressed on Biktarvy (SOUND)

Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
An open-label, pilot study of switching patients to Dovato who are currently taking Bitarvy who are virological suppressed (HIV-1 < 50 copies/mL
Phase:
Phase 4
Details
Lead Sponsor:
Saint Michael's Medical Center
Collaborator:
ViiV Healthcare
Treatments:
Dolutegravir
Lamivudine